US
Amplify Weight Loss Drug & Treatment ETF
THNR · Equity
$24.93
+0.54%
Assets
n/a
Expense ratio
0.59%
Holdings
22
1Y return
+18.7%
Forward P/E
n/a
Top 10 holdings
+70.6%
Return and risk
| 1Y total return | +18.7% |
| 3Y total return | n/a |
| 5Y total return | n/a |
| 3Y CAGR | n/a |
| 5Y CAGR | n/a |
| Beta | 0.41 |
| RSI | 55.13 |
Fund structure
| Asset class | Equity |
| Assets | n/a |
| Holdings | 22 |
| Expense ratio | 0.59% |
| Dividend yield | +1.7% |
| Top 10 holdings | +70.6% |
| Volume | 2.8K |
All ETF indicators
| All Time High | 28.19 |
| All Time High Change | -11.56 |
| All Time High Date | 2024-08-30 |
| All Time Low | 18.56 |
| All Time Low Change | 34.35 |
| All Time Low Date | 2025-04-07 |
| Atr | 0.35 |
| Beta | 0.41 |
| Cagr1y | 18.7 |
| Ch1m | 1.12 |
| Ch1w | 0.73 |
| Ch1y | 16.8 |
| Ch3m | -4.67 |
| Ch6m | 1.93 |
| Ch YTD | -1.13 |
| Close | 24.8 |
| Dividend Growth | 0 |
| Dividend Growth Years | 2 |
| Dividend Years | 2 |
| Dividend Yield | 1.66 |
| Dps | 0.41 |
| Ex Div Date | 2025-12-30 |
| High52 | 27.28 |
| High52ch | -8.6 |
| High52 Date | 2026-01-20 |
| Inception Date | 2024-05-21 |
| Isin | US0321085328 |
| Last Dividend | 0.41 |
| Low52 | 20.98 |
| Low52ch | 18.85 |
| Low52 Date | 2025-05-12 |
| Ma150 | 24.97 |
| Ma150ch | -0.15 |
| Ma20 | 24.59 |
| Ma200 | 24.5 |
| Ma200ch | 1.76 |
| Ma20ch | 1.38 |
| Ma50 | 24.52 |
| Ma50ch | 1.68 |
| Payment Date | 2025-12-31 |
| Payout Frequency | Annual |
| Payout Ratio | 31.05 |
| Price Date | 2026-05-12 |
| Rsi | 55.13 |
| Rsi Monthly | 49.78 |
| Rsi Weekly | 51.22 |
| Sharpe Ratio | 0.78 |
| Sortino Ratio | 1.48 |
| Top10holdings | 70.64 |
| Tr1m | 1.12 |
| Tr1y | 18.69 |
| Tr3m | -4.68 |
| Tr6m | 3.58 |
| Tr YTD | -1.13 |